KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adaptive Biotechnologies (ADPT) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Adaptive Biotechnologies (ADPT) over the last 8 years, with Q3 2025 value amounting to $428000.0.

  • Adaptive Biotechnologies' Amortizatization of Intangibles changed 0.0% to $428000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year decrease of 4938.02%. This contributed to the annual value of $8.2 million for FY2024, which is 1062.72% down from last year.
  • As of Q3 2025, Adaptive Biotechnologies' Amortizatization of Intangibles stood at $428000.0, which was down 0.0% from $423000.0 recorded in Q2 2025.
  • Adaptive Biotechnologies' 5-year Amortizatization of Intangibles high stood at $3.5 million for Q4 2022, and its period low was -$2.1 million during Q1 2021.
  • For the 5-year period, Adaptive Biotechnologies' Amortizatization of Intangibles averaged around $692631.6, with its median value being $428000.0 (2021).
  • In the last 5 years, Adaptive Biotechnologies' Amortizatization of Intangibles crashed by 47913.67% in 2021 and then surged by 37595.93% in 2022.
  • Adaptive Biotechnologies' Amortizatization of Intangibles (Quarter) stood at -$1.3 million in 2021, then soared by 375.96% to $3.5 million in 2022, then decreased by 16.03% to $3.0 million in 2023, then tumbled by 50.73% to $1.5 million in 2024, then tumbled by 70.64% to $428000.0 in 2025.
  • Its last three reported values are $428000.0 in Q3 2025, $423000.0 for Q2 2025, and $958000.0 during Q1 2025.